Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAcuity RM Group plc Regulatory News (ACRM)

Share Price Information for Acuity RM Group plc (ACRM)

Share Price is delayed by 15 minutes
Get Live Data
0.75    -0.175 (-18.92%)
Bid:
0.70
Ask:
0.80
Spread: 0.10 (14.286%)
Market Cap: £1.83m
ACRM Live PriceLast checked at - London Stock Exchange

Intraday Acuity RM Group plc Share Chart

Issue of Equity

27 Mar 2026 07:00

Acuity RM Group Plc - Issue of Equity

Acuity RM Group Plc - Issue of Equity

PR Newswire

LONDON, United Kingdom, March 27

27 March 2026

 

Acuity RM Group plc ("Acuity", the "Company" or the "Group")

Issue of Equity

Director / PDMR Shareholding

 

Acuity (AIM: ACRM), the software group specialising in the cybersecurity sector of the Governance, Risk and Compliance ("GRC") market,   is pleased to announce that further the announcement made 13 June 2025 (the " Statement re Business and Directorate "), the Company has issued 2,201,408 ordinary shares of 0.1 pence each in the Company (“Ordinary Shares”) to certain Directors and a PDMR (as set out in the table below) in lieu of deferred salary to 31 December 2025 (“Salary Shares”).

In addition, the Company has agreed to settle £23,207 of two supplier invoices by way of the issue of 2,670,847 new Ordinary Shares (“Supplier Shares”). The Salary Shares have been issued at 1.1026 pence per share, being the average of the closing share prices over the period of salary deferral to 31 December 2025. 1,242,276 of the Supplier Shares have been issued at a price of 0.8619 pence per share, being the average of the closing share prices in January 2026, and 1,428,571 shares at 0.8750 pence per share, being the closing mid-market price on 17 March 2026.

 

Name

Role

Shares in lieu of deferred salary

Original holding prior

Total holding after Admission of the Salary Shares

Percentage holding of the enlarged share capital after Admission

Angus Forrest

Non-exec Chairman

484,104

  7,925,841

8,409,945

3.4%

Nick Clark

Non Exec

Director

528,523

11,938,712

12,467,235

5.1%

John Wakefield

Non Exec

Director

612,189

1,388,822

2,001,011

0.8%

Simon Marvell

PDMR

576,592

33,647,998

34,224,590

14.0%

Admission and Total Voting Rights

Application has been made to the London Stock Exchange for the Salary Shares and the Supplier Shares to be admitted to trading on AIM ("Admission") and it is expected that such Admission will occur at 8.00 a.m. on 31 March 2026. The Subscription Shares will be issued credited as fully paid and will rank in full for all dividends and other distributions declared, made or paid after the admission of the Subscription Shares, respectively and will otherwise be identical to and rank on Admission pari passu in all respects with the existing Ordinary shares.

Following Admission of the Salary Shares and the Supplier Shares , the Company will have 244,490,504 Ordinary Shares in issue, of which none are held in treasury. Accordingly, the total number of voting rights in the Company will be 244,490,504 and shareholders may use this figure as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

 

For further information please contact :

 

Acuity RM Group plc

https://www.acuityrmgroup.com

Angus Forrest

+44 (0) 20 3582 0566

Zeus (NOMAD & Joint Broker)

https://www.zeuscapital.co.uk

Mike Coe / James Bavister

+44 (0) 20 3582 0566

 

AlbR Capital (Joint broker)

 

Lucy Williams / Duncan Vasey

+44 (0) 20 7469 0936

 

Clear Capital (Joint broker)

 

Bob Roberts

+44 (0) 20 3869 6080

Note to Editors

Acuity RM Group plc

Acuity RM Group plc (AIM: ACRM), is an established provider of risk management services. Its award-winning STREAM® software platform which collects and analyses data to improve business decisions and management is used by clients operating in markets including government, defence, broadcasting, utilities, manufacturing and healthcare .

The Company is focused on delivering long term, sustainable growth in shareholder value from organic growth and complementary acquisitions.

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Angus Forrest

2

Reason for the notification

a)

Position/status

Non-executive Chairman

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

  Acuity RM Group Plc

b)

LEI

213800JHJFKALDJA5X97

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares

 

ISIN:   GB00BR0WHY71

 

b)

Nature of the transaction

Subscription of new   s hares pursuant to conversion of salary

c)

Price(s) and volume(s)

  Price(s)

Volume(s)

1.1026p

484,104

d)

Aggregated information

- Aggregated volume

- Price

 

 

484,104

£5,337.73

e)

Date of the transaction

  31 March   2026

f)

Place of the transaction

Outside a trading venue

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Nick Clark

2

Reason for the notification

a)

Position/status

Non-executive director

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

  Acuity RM Group Plc

b)

LEI

213800JHJFKALDJA5X97

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares

 

ISIN:   GB00BR0WHY71

b)

Nature of the transaction

Subscription of new   s hares pursuant to conversion of salary

c)

Price(s) and volume(s)

  Price(s)

Volume(s)

1.1026p

528,523

d)

Aggregated information

- Aggregated volume

- Price

 

 

528,523

£5,827.50

e)

Date of the transaction

  31 March   2026

f)

Place of the transaction

Outside a trading venue

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

John Wakefield

2

Reason for the notification

a)

Position/status

Non-executive director

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

  Acuity RM Group Plc

b)

LEI

213800JHJFKALDJA5X97

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares

 

ISIN:   GB00BR0WHY71

b)

Nature of the transaction

Subscription of new   s hares pursuant to conversion of salary

c)

Price(s) and volume(s)

  Price(s)

Volume(s)

1.1026p

612,189

d)

Aggregated information

- Aggregated volume

- Price

 

 

612,189

£6,750.00

e)

Date of the transaction

  31 March   2026

f)

Place of the transaction

Outside a trading venue

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Simon Marvell

2

Reason for the notification

a)

Position/status

PDMR

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

  Acuity RM Group Plc

b)

LEI

213800JHJFKALDJA5X97

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares

 

ISIN:   GB00BR0WHY71

b)

Nature of the transaction

Subscription of new   s hares pursuant to conversion of salary

c)

Price(s) and volume(s)

  Price(s)

Volume(s)

1.1026p

576,592

d)

Aggregated information

- Aggregated volume

- Price

 

 

576,592

£6,357.50

e)

Date of the transaction

31 March   2026

f)

Place of the transaction

Outside a trading venue

 



12
Date   Source Headline
17th Jun 20267:00 amPRNRetail Offer
16th Jun 20264:33 pmRNSFundraise of approximately £400,000
8th Jun 20267:00 amRNS-RContract Expansion
24th Apr 20267:00 amPRNTrading Statement
23rd Apr 20267:00 amPRNTrading Statement
27th Mar 20267:00 amPRNIssue of Equity
16th Mar 20267:00 amRNSProduct Launch
16th Mar 20267:00 amPRNProduct Launch
9th Mar 20267:00 amRNS-RA client’s experience of Acuity
24th Feb 20267:00 amRNS-RContract win
17th Feb 20267:00 amPRNContract
5th Feb 20262:35 pmPRNDirector/PDMR Shareholding
5th Feb 20261:17 pmPRNPDMR Shareholding
4th Feb 20267:00 amPRNHolding in Company
2nd Feb 20267:00 amPRNContract
15th Jan 20268:07 pmPRNHoldings in Company and Director Dealing
15th Jan 20267:00 amPRNStatement re Investor Presentation 10.00am 21 January
13th Jan 20267:00 amPRNTrading Statement
18th Nov 20258:47 amRNSHolding(s) in Company
17th Nov 20257:00 amPRNStatement re sale of investment
13th Nov 20254:06 pmPRNHolding(s) in Company
12th Nov 20257:00 amPRNDirectorate changes
21st Oct 20257:00 amRNS-RContract Win
7th Oct 20257:00 amPRNContract
22nd Sep 20257:00 amPRNIssue of Equity
16th Sep 20251:03 pmPRNHolding(s) in Company
5th Sep 20257:00 amPRNStatement re Investor presentation 10.00am 11 September
2nd Sep 20257:00 amPRNHalf-year Report
18th Aug 20257:00 amRNS-RFirst customer win for new product
30th Jul 20251:52 pmPRNResult of AGM
29th Jul 20257:00 amPRNIssue of Equity
11th Jul 202511:33 amPRNHolding(s) in Company
7th Jul 20254:09 pmPRNAnnual Report and Notice of AGM
7th Jul 202512:23 pmPRNHolding(s) in Company
7th Jul 20257:00 amPRNProduct Launch
4th Jul 202511:56 amPRNHolding(s) in Company
2nd Jul 20257:00 amPRNStatement re Final Results
30th Jun 20251:54 pmPRNIssue of Equity
26th Jun 20256:04 pmPRNHolding(s) in Company
25th Jun 20259:30 amRNSFinal Results
19th Jun 20253:22 pmPRNHolding(s) in Company
13th Jun 202510:30 amPRNStatement re Business and Directorate
21st May 20257:00 amPRNIssue of Equity
19th May 20259:45 amPRNIssue of Equity
19th May 20257:00 amPRNIssue of Equity
6th Mar 20257:00 amPRNStatement re Investor Presentation
17th Feb 20257:00 amPRNDirector/PDMR Shareholding
7th Feb 20257:00 amPRNChanges in share options
5th Feb 20258:59 amPRNCorrection to Year end Update
4th Feb 20257:00 amPRNTrading Statement
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.